Long-term assessment of NFκB expression in the brain and neurologic outcome following deep hypothermic circulatory arrest in rats

Perfusion

Volumn 24, Issue 6, 2009, Pages 429-436

  Kellermann, Kristine ^a   Gordan, M Lucia ^a   Nollert, Georg ^b,c   Blobner, Manfred ^a   Kochs, Eberhard F ^a   Jungwirth, Bettina ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c SIEMENS AG   (Germany)

Author keywords

Cardiopulmonary bypass; Cerebral inflammation; Cerebral ischemia; Deep hypothermic circulatory arrest; Neurologic deficits; Nuclear Factor Kappa B

Indexed keywords

CYCLOOXYGENASE 2; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; BRAIN TISSUE; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DEEP HYPOTHERMIC CIRCULATORY ARREST; ENZYME ACTIVITY; EXPERIMENTAL RAT; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MALE; MOTOR CORTEX; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; BRAIN; BRAIN ISCHEMIA; CARDIOPULMONARY BYPASS; CIRCULATORY ARREST, DEEP HYPOTHERMIA INDUCED; GENE EXPRESSION REGULATION; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TREATMENT OUTCOME;

EID: 76149128367     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659109358655     Document Type: Article

References (25)

1. Bellinger DC, Jonas RA, Rappaport LA, et al. Developmental and neurologic status of children after heart surgery with hypothermic circulatory arrest or low-flow cardiopulmonary bypass [see comments]. N Engl J Med 1995 ; 332: 549-555.
2. Limperopoulos C., Majnemer A., Shevell MI, et al. Predictors of developmental disabilities after open heart surgery in young children with congenital heart defects. J Pediatr 2002 ; 141: 51-58.
3. Mathew JP, Grocott HP, Phillips-Bute B., et al. Lower endotoxin immunity predicts increased cognitive dysfunction in elderly patients after cardiac surgery. Stroke 2003 ; 34: 508-513.
4. Pahl HL Activators and target genes of rel/nf-kappab transcription factors. Oncogene 1999 ; 18: 6853-6866.
5. Nijboer CH, Heijnen CJ, Groenendaal F., et al. Strong neuroprotection by inhibition of nf-kappab after neonatal hypoxia-ischemia involves apoptotic mechanisms but is independent of cytokines. Stroke 2008 ; 39: 2129-2137.
6. Yenari MA, Han HS Influence of hypothermia on post-ischemic inflammation: role of nuclear factor kappa b (nfkappab). Neurochem Int 2006 ; 49: 164-169.
7. Jungwirth B., Mackensen GB, Blobner M., et al. Neurologic outcome after cardiopulmonary bypass with deep hypothermic circulatory arrest in rats: description of a new model. J Thorac Cardiovasc Surg 2006 ; 131: 805-812.
8. Liao J., Xu X., Wargovich MJ Direct reprobing with anti-beta-actin antibody as an internal control for western blotting analysis. Biotechniques 2000 ; 28: 216-218.
9. Newton R., Kuitert LM, Bergmann M., et al. Evidence for involvement of NF-kappaB in the transcriptional control of COX-2 gene expression by IL-1beta. Biochem Biophys Res Commun 1997 ; 237: 28-32.
10. Zhao X., Zhang Y., Strong R., et al. J. Distinct patterns of intracerebral hemorrhage-induced alterations in nf-kappab subunit, inos, and cox-2 expression. J Neurochem 2007 ; 101: 652-663.
11. Ye SM, Johnson RW Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappab. J Neuroimmunol 2001 ; 117: 87-96.
12. Blondeau N., Widmann C., Lazdunski M., et al. Activation of the nuclear factor-kappab is a key event in brain tolerance. J Neurosci 2001 ; 21: 4668-4677.
13. Nurmi A., Lindsberg PJ, Koistinaho M., et al. Nuclear factor-kappab contributes to infarction after permanent focal ischemia. Stroke 2004 ; 35: 987-991.
14. Malek S., Chen Y., Huxford T., et al. Ikappa2, but not Ikappa2-alpha, functions as a classical cytoplasmic inhibitor of nf-kappab dimers by masking both nf-kappab nuclear localization sequences in resting cells. J Biol Chem 2001 ; 276: 45225-45235.
15. Verma IM Nuclear factor (nf)-kappab proteins: therapeutic targets. Ann Rheum Dis 2004 ; 63 Suppl 2: ii57 - ii61.
16. Nogawa S., Zhang F., Ross ME, et al. Cyclo-oxygenase-2 gene expression in neurons contributes to ischemic brain damage. J Neurosci 1997 ; 17: 2746-2755.
17. Gilroy DW, Colville-Nash PR, Willis D., et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med 1999 ; 5: 698-701.
18. Nakayama M., Uchimura K., Zhu RL, et al. Cyclooxygenase-2 inhibition prevents delayed death of ca1 hippocampal neurons following global ischemia. Proc Natl Acad Sci U S A 1998 ; 95: 10954-10959.
19. Schmidt-Kastner R., Freund TF Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991 ; 40: 599-636.
20. Gong C., Ennis SR, Hoff JT, et al. Inducible cyclooxygenase-2 expression after experimental intracerebral hemorrhage. Brain Res 2001 ; 901: 38-46.
21. Hindman BJ, Moore SA, Cutkomp J., et al. Brain expression of inducible cyclooxygenase 2 messenger rna in rats undergoing cardiopulmonary bypass. Anesthesiology 2001 ; 95: 1380-1388.
22. Yaron A., Gonen H., Alkalay I., et al. Inhibition of nf-kappab cellular function via specific targeting of the i-kappa-b-ubiquitin ligase. Embo J 1997 ; 16: 6486-6494.
23. de Lange F., Jones WL, Mackensen GB, et al. The effect of limited rewarming and postoperative hypothermia on cognitive function in a rat cardiopulmonary bypass model. Anesth Analg 2008 ; 106: 739-745.
24. de Lange F., Dieleman JM, Jungwirth B., et al. Effects of cardiopulmonary bypass on neurocognitive performance and cytokine release in old and diabetic rats. Br J Anesth 2007 ; 99: 177-183.
25. Mackensen GB, Sato Y., Nellgard B., et al. Cardiopulmonary bypass induces neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2001 ; 95: 1485-1491.